| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Familial partial lipodystrophy fpld 0.8622600437484592 2.646321047734987 0.0081372546849947 0.9926911314208304 0.6015264612349821 8 O75844,O60725 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.7360071167891081 2.6347164104266207 0.0084207605028341 0.9938466712041376 0.6015264612349821 23 Q15392,P48449,Q9BWD1,P35610,Q16850,Q14739,O76062,P37268 8 |
| Sphingolipid pathway 0.7726307561011857 2.583373678262461 0.0097839288774663 0.997311919252988 0.6015264612349821 11 Q8N5B7,Q06136,Q9Y5P4,P04062,Q9NRA0,Q96G23 6 |
| Sphingolipid metabolism in senescence 0.7579996455320243 2.5091265091192474 0.0121030129963974 0.9993447306618732 0.6015264612349821 11 P16278,P24941,P04062,Q96G23 4 |
| Sphingolipid metabolism integrated pathway 0.7859380555241834 2.482204974680964 0.0130572142051672 0.9996337563835146 0.6015264612349821 9 Q8N5B7,P27544,Q06136,O95470,Q9NRA0,Q96G23 6 |
| Allograft rejection 0.7676338629960202 2.4722235280607223 0.0134275529292688 0.9997078220930372 0.6015264612349821 10 P08670,P55210,P08183,P04439 4 |
| Nephrotic syndrome 0.7311609069458987 2.4609226124492296 0.0138580253996618 0.9997753296756836 0.6015264612349821 12 O75844,Q86YH6,Q14108 3 |
| Progeriaassociated lipodystrophy 0.7510160741965177 2.3891547259799424 0.0168871886871668 0.9999647450528976 0.6015264612349821 10 O60725 1 |
| Statin inhibition of cholesterol production 0.8639914853108516 2.312323654807663 0.0207598540688027 0.9999967242979808 0.6015264612349821 6 Q8WTV0,P37268,P35610 3 |
| Metabolism of spingolipids in er and golgi apparatus 0.9186262376237644 2.268765309585679 0.0232826016102147 0.9999993067462846 0.6015264612349821 4 Q06136,Q10472,Q9NRA0 3 |
| Sphingolipid metabolism overview 0.7742029246290942 2.2417066970720745 0.0249803347688946 0.9999997567505822 0.6015264612349821 8 P27544,Q06136,O95470,Q96G23,Q9NRA0 5 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.7069976226228265 2.091852797687842 0.0364516856590009 0.9999999998041856 0.621602193012888 9 P35610,Q9BWD1 2 |
| Ketogenesis and ketolysis 0.8084180338889944 2.0748342762398675 0.0380018966710891 0.999999999925719 0.621602193012888 6 P23786,O43772,P53985 3 |
| Cholesterol biosynthesis pathway 0.6592838997164696 2.0726508399416006 0.0382047859492971 0.9999999999345768 0.621602193012888 12 Q16850,P37268,P48449 3 |
| Zinc homeostasis 0.8592869760443638 2.027632763302497 0.0425977425556327 0.9999999999958422 0.6255398386964525 4 Q8TAD4,Q15043 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7859941963452803 1.9772565811263387 0.0480126348471252 0.9999999999998632 0.6721768878597536 6 P07099 1 |
| Influence of laminopathies on wnt signaling 0.6268192365132853 1.891715090467602 0.0585289516213434 0.9999999999999998 0.673466971480115 12 O60725 1 |
| Riboflavin and coq disorders 0.7596689618327626 1.861460250198479 0.0626792089997168 1.0 0.673466971480115 6 O75208,Q86YH6,Q8NFF5 3 |
| Vitamin d receptor pathway 0.6463746262292358 1.847171022177163 0.0647223577471465 1.0 0.673466971480115 10 P24941,P08183 2 |
| Nucleotide metabolism 0.6037503036181042 1.8437390986992517 0.0652211720069562 1.0 0.673466971480115 13 P00374 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.576581311328666 1.8423417828517512 0.0654251716476861 1.0 0.673466971480115 16 P11802,O60725,O75844,P42167,P55209,P48729 6 |
| Kennedy pathway from sphingolipids 0.7822404962862782 1.8313294535660267 0.0670513839794524 1.0 0.673466971480115 5 O95470,Q9Y6K0,P35790 3 |
| Fluoropyrimidine activity 0.61435703680968 1.8213703586408516 0.0685505777930763 1.0 0.673466971480115 12 P00374,Q92820,Q06203,Q99808,P31350 5 |
| Oxidation by cytochrome p450 0.7486242776526888 1.812492268058116 0.0699101675646673 1.0 0.673466971480115 6 O43169,Q6UW02,Q16850 3 |
| Proteoglycan biosynthesis 0.7737284768019139 1.794605768276282 0.0727165334654609 1.0 0.673466971480115 5 Q8NCH0,Q8TB61 2 |
| Familial hyperlipidemia type 4 0.7957929309989977 1.7634310631946122 0.0778278145615476 1.0 0.6886011487392784 4 P01130 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.73631324141309 1.75765118711719 0.0788068781223461 1.0 0.6886011487392784 6 Q15392,Q16850 2 |
| Glycosaminoglycan degradation 0.6848771260156625 1.6607661132875993 0.0967604294017778 1.0 0.7281222312483784 7 P51688,P54802,P08236,P16278,P15586 5 |
| Reninangiotensinaldosterone system raas 0.8941271939066185 1.6234354962415378 0.1044963418477884 1.0 0.7318821924085717 3 Q14012 1 |
| Striated muscle contraction pathway 0.7043731278835538 1.614174444404464 0.1064895935054532 1.0 0.7318821924085717 6 P09493,P06753,P08670 3 |
| Folate metabolism 0.5393406835232604 1.6082664635874937 0.1077768322428376 1.0 0.7318821924085717 16 Q8WTV0,P00374,P01130,P41440 4 |
| Metapathway biotransformation phase i and ii 0.563552814367105 1.599081289266973 0.109802541559224 1.0 0.7318821924085717 23 P34913,Q16850,Q8NCH0,O43708,Q86UY6,Q6UW02,P07099 7 |
| Spinal cord injury 0.5512011728651113 1.5890663888718928 0.1120454050843147 1.0 0.7318821924085717 20 P11802,P17252,P24941,P62942,P14174,P08670,P06493,Q9NQC3,P27695 9 |
| Sarscov2 and covid19 pathway 0.7535411271274176 1.5845665192919811 0.1130648569667727 1.0 0.7318821924085717 4 Q8WTV0,P35610 2 |
| Small cell lung cancer 0.5283836874042134 1.562840193128602 0.1180901877173383 1.0 0.7478179920774015 15 P31751 1 |
| Vitamin a and carotenoid metabolism 0.7154684359357819 1.5404025615180796 0.1234622574238097 1.0 0.75075029261751 5 Q8WTV0,Q6NUM9 2 |
| Familial hyperlipidemia type 3 0.8680897780320826 1.5241797809805284 0.1274638073664449 1.0 0.7673321203459984 3 Q8WTV0 1 |
| Relationship between inflammation cox2 and egfr 0.7341578294598203 1.5018646397363768 0.1331320703527945 1.0 0.7857402583566891 4 P31751 1 |
| Ferroptosis 0.5462448012866638 1.423888671015078 0.1544787018069435 1.0 0.8555937231513353 26 P09601,Q9UKU0,Q6P1A2,P37268,P16435,P45880,Q9NZ45,Q15043 8 |
| 7oxoc and 7betahc pathways 0.5615435990793878 1.385620782750319 0.1658627287518843 1.0 0.8758716027073191 10 P34913 1 |
| Familial hyperlipidemia type 5 0.8278192498520924 1.3700979006149088 0.1706563430970031 1.0 0.8824352774350235 3 P01130 1 |
| Familial hyperlipidemia type 1 0.8278192498520924 1.3700979006149088 0.1706563430970031 1.0 0.8824352774350235 3 P01130 1 |
| 1q211 copy number variation syndrome 0.5679518573330479 1.3631961458382964 0.172820701615505 1.0 0.8824352774350235 9 Q86WJ1,Q9NPH0 2 |
| Head and neck squamous cell carcinoma 0.5009673779320171 1.3627254906002266 0.1729690410919149 1.0 0.8824352774350235 16 P08069,P31751,Q8N122,P62942 4 |
| Mitochondrial long chain fatty acid betaoxidation 0.4925147799163304 1.3324459231869237 0.1827137001000705 1.0 0.8870455440342132 15 P23786,O43772 2 |
| Ethanol effects on histone modifications 0.5223178865713181 1.2887593987482229 0.1974817451774912 1.0 0.904601064791966 12 P00374 1 |
| Heme biosynthesis 0.6571186687376032 1.2821141470375508 0.1998026069497307 1.0 0.904601064791966 5 P22830 1 |
| Sulfation biotransformation reaction 0.6795994093658109 1.2677569123007482 0.2048847736922603 1.0 0.904601064791966 4 O43252 1 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.6167423413057573 1.213852966145674 0.2248038761813389 1.0 0.9219820432339004 6 Q9UPY5,P09601 2 |
| Vitamin b12 metabolism 0.5403157454839908 1.2136119764623647 0.2248959314844554 1.0 0.9219820432339004 9 Q8WTV0,P32929,Q96EY8,P01130 4 |
| Nanomaterial induced apoptosis 0.611274713008432 1.1887015668838803 0.2345571238234658 1.0 0.9219820432339004 6 O43464,Q9NR28,P55210,O95831 4 |
| Proximal tubule transport 0.4911912123216586 1.170518489679819 0.2417923778361705 1.0 0.9219820432339004 13 P08183,P05026 2 |
| Irinotecan pathway 0.9607297464440354 1.1482600813153856 0.2508612130637053 1.0 0.9219820432339004 2 O15118 1 |
| Copper homeostasis 0.5259106471880789 1.1353736423203638 0.2562187984917532 1.0 0.9219820432339004 9 P78536,P35670,Q9Y6N1,P05067,O43819 5 |
| Triacylglyceride synthesis 0.6230376463923881 1.130663202220394 0.2581968749370182 1.0 0.9219820432339004 5 Q9HCL2 1 |
| Eicosanoid synthesis 0.7639224598977667 1.125826730296413 0.2602388674945131 1.0 0.9219820432339004 3 Q9H7Z7 1 |
| Degradation pathway of sphingolipids including diseases 0.571629222951295 1.11589655612243 0.2644664161330454 1.0 0.9219820432339004 7 O43681,P16278,P06280 3 |
| Ovarian infertility 0.7566481047700426 1.0981763118336374 0.2721275078546847 1.0 0.9219820432339004 3 Q13315 1 |
| S1p receptor signal transduction 0.5145574989706989 1.073671819948866 0.282969795765984 1.0 0.9219820432339004 9 P31751,Q9NRA0 2 |
| Target of rapamycin tor signaling 0.5036258009032663 1.0632547062776474 0.287666459507212 1.0 0.9219820432339004 10 P54619,P17252,Q8N122,P62942 4 |
| Adipogenesis 0.4505283975997348 1.0601456163648326 0.2890783578385061 1.0 0.9219820432339004 15 P43490,P14174,O75844,Q9NZ45,Q9NR56 5 |
| G1 to s cell cycle control 0.4879868232325703 1.0520955942302324 0.292755693310927 1.0 0.9219820432339004 26 Q13315,Q14566,P24941,P06493,Q9Y619,O43913,Q99640,P56282 8 |
| Estrogen receptor pathway 0.7437425871443001 1.0492695560259762 0.2940540735895496 1.0 0.9219820432339004 3 Q9HCL2 1 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.5769802170107207 1.03110994724906 0.3024892636152474 1.0 0.9288220619959752 6 Q9UPY5,P09601 2 |
| Selenium micronutrient network 0.4770453426406909 1.021712955116711 0.306916777660094 1.0 0.9288220619959752 12 Q8WTV0,P30048,P01130 3 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.474933864569345 1.0092633358650662 0.312848358745645 1.0 0.9323500592320708 12 P31751,P24941 2 |
| Oncostatin m signaling pathway 0.4479497083096327 0.996049066095196 0.3192263056656885 1.0 0.94203056868012 17 P17252,P24941,P62993,P40763,P20248,P01130,P55210 7 |
| Proteasome degradation 0.5187935500555891 0.9539374517294882 0.3401153044389526 1.0 0.9839174834557096 41 P28072,P28074,P25787,O00231,P28070,P20618,P04439,Q06323,Q99436,O75832,P60900,Q9UL46,P49721,P61289,P49720 15 |
| Camkk2 pathway 0.4625077648921272 0.93611400626997 0.3492144923496609 1.0 0.9946356047759416 12 O00429,P09601,Q8N122,Q14012,Q9Y3D6 5 |
| Apoptosis modulation by hsp70 0.7117333191747777 0.9290741523967062 0.3528506587257327 1.0 0.9946356047759416 3 P55210 1 |
| Familial hyperlipidemia type 2 0.8967223252937704 0.9236043411349688 0.3556923528075109 1.0 0.9946356047759416 2 P34913 1 |
| Inclusion body myositis 0.8942486085343224 0.9150884516644868 0.3601451970570644 1.0 0.9946356047759416 2 P05067 1 |
| Onecarbon metabolism and related pathways 0.4363443968632222 0.8992406386340464 0.3685244984931601 1.0 1.0 14 Q9Y6K0,P35790,P00390,O43865,P32929 5 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.5684994479192115 0.8902064387846834 0.3733550479605325 1.0 1.0 5 O00767,P01130 2 |
| Metabolic pathway of ldl hdl and tg including diseases 0.695560439646672 0.869151459941088 0.3847642930499018 1.0 1.0 3 Q8WTV0 1 |
| Hippoyap signaling pathway 0.5848871578773559 0.864188486314112 0.387484356081524 1.0 1.0 4 O95819,Q13188 2 |
| Caloric restriction and aging 0.6911280798170454 0.8528468241313824 0.3937442536391136 1.0 1.0 3 P43490 1 |
| Sting pathway in kawasakilike disease and covid19 0.6815714780012001 0.8178865293957583 0.4134219828210095 1.0 1.0 3 Q86UT6 1 |
| Mitochondrial complex iv assembly 0.4311290726626963 0.8065652896016609 0.4199169783078216 1.0 1.0 13 Q9Y6N1,P14406,Q9Y2R0 3 |
| Disruption of postsynaptic signaling by cnv 0.5009819837724558 0.7763749406285672 0.4375276363794937 1.0 1.0 7 Q7L576 1 |
| Mitochondrial complex iii assembly 0.4577869206311813 0.7672254242680281 0.4429474991571045 1.0 1.0 9 Q9UDW1 1 |
| Nrf2are regulation 0.4576436566364453 0.7664622905393634 0.443401281276397 1.0 1.0 9 P09601 1 |
| Fatty acid betaoxidation 0.4292765030904246 0.764934445347297 0.4443105814487555 1.0 1.0 22 P23786,O43772,P35610 3 |
| Vitamin d in inflammatory diseases 0.5569595800296713 0.7488542097442867 0.4539450818662751 1.0 1.0 4 O60244 1 |
| Congenital generalized lipodystrophy cgl 0.8385899814471455 0.7283079191272298 0.4664251157492409 1.0 1.0 2 P31751 1 |
| Cancer immunotherapy by pd1 blockade 0.6542270838770807 0.7195629828392213 0.4717941104541199 1.0 1.0 3 P04439 1 |
| Male infertility 0.42605421378108 0.7027755375635875 0.4821956443730608 1.0 1.0 24 Q15165,Q13315,P08183,P41440 4 |
| Complement system in neuronal development and plasticity 0.4281591663397818 0.6892487591630349 0.4906667375706464 1.0 1.0 11 Q9NR28,Q5KU26,P55210 3 |
| Glioblastoma signaling pathways 0.4095212604733944 0.6842830187322094 0.4937964678491822 1.0 1.0 20 P08069,P31751,Q13315,P24941,P62993 5 |
| Ebsteinbarr virus lmp1 signaling 0.5189841967316202 0.6783540180005017 0.4975472563657319 1.0 1.0 5 O14920,Q9NR12 2 |
| Endochondral ossification 0.4594867456593292 0.6717669115408088 0.5017320965664331 1.0 1.0 8 P08069,Q9Y376,Q96QD8 3 |
| Endochondral ossification with skeletal dysplasias 0.4594867456593292 0.6717669115408088 0.5017320965664331 1.0 1.0 8 P08069,Q9Y376,Q96QD8 3 |
| Autophagy 0.4783497762626235 0.6705618190149616 0.5024997124369359 1.0 1.0 7 Q7Z3C6,Q8N122,Q9Y4P8,P54619 4 |
| Dna replication 0.440184480355051 0.6700518992488921 0.5028247063296809 1.0 1.0 30 P24941,Q9Y619,P56282,P41440 4 |
| Neuroinflammation 0.5134736051481625 0.6554351428839985 0.5121876312655123 1.0 1.0 5 P00403,Q8N9N2 2 |
| 15q112 copy number variation syndrome 0.6303766863921569 0.6363458315227392 0.5245510387585195 1.0 1.0 3 Q7L576 1 |
| Nucleotidebinding oligomerization domain nod pathway 0.4316462275749809 0.6295904532941115 0.5289625712608863 1.0 1.0 9 P55210,Q9P0J0,O14920 3 |
| Endothelin pathways 0.43007090875991 0.6214196493788201 0.5343235468522509 1.0 1.0 9 P00403,P16615,P42892 3 |
| Erk pathway in huntingtons disease 0.6194527815633109 0.5991876439487174 0.5490477614486278 1.0 1.0 3 P55210 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.4779365341991454 0.5893945262694681 0.5555966475678844 1.0 1.0 6 Q9BXK5,P23229,Q07820,P49840 4 |
| Tyrobp causal network in microglia 0.4605194946223851 0.5890899996241412 0.5558009015053256 1.0 1.0 7 O15439,Q5T1M5,P61916,Q15418 4 |
| Nad biosynthetic pathways 0.6125420692639403 0.5760298938113634 0.5645949759178199 1.0 1.0 3 Q8IXJ6 1 |
| Nad metabolism 0.6125420692639403 0.5760298938113634 0.5645949759178199 1.0 1.0 3 Q8IXJ6 1 |
| Integrated cancer pathway 0.3874363819653502 0.5506045579824246 0.5819047836426234 1.0 1.0 13 P24941,Q13315,P06493 3 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3799734865626699 0.5456274930616668 0.5853220218411237 1.0 1.0 18 P31751,Q96KP1,Q9UJX6 3 |
| Pilocytic astrocytoma 0.5991339313331128 0.5319395501747234 0.5947678636967231 1.0 1.0 3 Q06124,P62993 2 |
| Interactions between loxl4 and oxidative stress pathway 0.7665429808286925 0.5061532603405113 0.6127490637316568 1.0 1.0 2 Q16543 1 |
| Glycerophospholipid biosynthetic pathway 0.4043495378598172 0.4907031644503554 0.6236364080240167 1.0 1.0 9 Q9Y6K0,O15228,Q9HCL2 3 |
| Vitamin d metabolism 0.5854293162852517 0.4881247385459434 0.6254614893110879 1.0 1.0 3 P04062 1 |
| Dna mismatch repair 0.3785607885727311 0.4764945645323613 0.6337220787979105 1.0 1.0 21 Q9NR33,P56282,P41440 3 |
| Exrna mechanism of action and biogenesis 0.5753170429941206 0.4566815027254516 0.6478999879905691 1.0 1.0 3 Q9HAV4,Q8WYQ5 2 |
| Somatroph axis gh and its relationship to dietary restriction and aging 0.7309833024118706 0.4081792701394622 0.6831420661004572 1.0 1.0 2 P08069 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3976441922374157 0.401358351967337 0.6881563078995394 1.0 1.0 31 Q8WTV0,P48449,Q16850,Q9HCL2 4 |
| Hedgehog signaling pathway wp4249 0.4297569233493516 0.3943255422237982 0.6933407078668172 1.0 1.0 6 P98164,P48729 2 |
| Tryptophan metabolism 0.3427317884737485 0.3888347482939159 0.697398394180033 1.0 1.0 15 Q15392,P35610 2 |
| Apoptosis 0.3637904414231874 0.3824941581421003 0.7020948612280513 1.0 1.0 12 P08069,Q9NR28,P55210 3 |
| Tnfalpha signaling pathway 0.350512974003716 0.374314875562367 0.7081700660995902 1.0 1.0 18 Q9NR28,P62993,Q16543,Q6GQQ9,P55210 5 |
| Autosomal recessive osteopetrosis pathways 0.5423706587374699 0.3601572411203708 0.7187295486475718 1.0 1.0 3 O14920 1 |
| Hepatitis b infection 0.3632590735091003 0.3344290608007953 0.7380558132050175 1.0 1.0 24 P31751,P17252,O14920,P62993,Q15904,Q9Y277,O00571 7 |
| Fibrin complement receptor 3 signaling pathway 0.5310480646907625 0.3293115828179354 0.7419201901216987 1.0 1.0 3 O14920 1 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3394613180376117 0.2934996099126448 0.7691402976172137 1.0 1.0 13 P31751,Q8N122 2 |
| Complement system 0.3404726731297375 0.2678225037300984 0.7888359478423539 1.0 1.0 12 P98164,P48729,P26885 3 |
| Signal transduction through il1r 0.4071024947065447 0.2619826142001374 0.7933348460486223 1.0 1.0 5 Q9BQ95 1 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.3434730341185067 0.2550313431911488 0.7986988910847967 1.0 1.0 11 P31751 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3502359746157304 0.2404732429041897 0.8099634038264454 1.0 1.0 9 P08069,P42345,Q8N122,P49770,Q13418 5 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.4942777605938797 0.2385060183432107 0.811488648060716 1.0 1.0 3 P28482,O14920 2 |
| Tolllike receptor signaling related to myd88 0.4942777605938797 0.2385060183432107 0.811488648060716 1.0 1.0 3 P28482,O14920 2 |
| Cohesin complex cornelia de lange syndrome 0.3236864824069995 0.2321844188047844 0.8163947791034118 1.0 1.0 18 P30154,P06493,Q96GD4,P30153,Q7Z5K2 5 |
| Dna damage response 0.3302510520821217 0.1990950279516916 0.8421884104953161 1.0 1.0 22 P11802,Q13315,P41440,P24941,P06493,Q00535 6 |
| Alzheimers disease 0.4858593757673178 0.1978032698202 0.8431989877747084 1.0 1.0 84 O14920,Q9Y4P8,P05067,P60900,P12235,P49721,P78536,P16615,P28070,P20618,P45880,Q00535,P21796,P49720,P25787,P28074,Q9H0B6,Q9Y277,Q92542,P28072,P48729,Q99436,P31751,O43242,Q9UJX6,Q07866,O95197,Q9NQC3,Q9BUF5,P67870,P55210 31 |
| Vitamin b12 disorders 0.3937720331447091 0.1901403747873087 0.8491991326379233 1.0 1.0 4 Q96EY8,Q9NPF0 2 |
| Wnt signaling pathway and pluripotency 0.3129755780998655 0.1802902957270596 0.8569246737309899 1.0 1.0 18 P17252,P30154,Q16537,P01130,P30153 5 |
| Mirna regulation of dna damage response 0.3294971081393311 0.1800091635944175 0.8571453742055168 1.0 1.0 23 P11802,Q13315,P41440,P24941,P06493,Q00535 6 |
| Endometrial cancer 0.3026231636870309 0.1796395906024452 0.8574355214407898 1.0 1.0 15 P31751,Q9UJX6 2 |
| Alzheimers disease and mirna effects 0.4839829811697304 0.1710682930164872 0.8641700668399286 1.0 1.0 86 O14920,Q9Y4P8,P05067,P60900,P12235,P49721,P78536,P16615,P28070,P20618,P45880,Q00535,P21796,P49720,P25787,P28074,Q9H0B6,Q9Y277,Q92542,P28072,P48729,Q99436,P31751,O43242,Q9UJX6,Q07866,O95197,Q9NQC3,Q9BUF5,P67870,P55210 31 |
| Type ii diabetes mellitus 0.3691761075592957 0.1558144174907391 0.8761793059170715 1.0 1.0 5 O14920,Q15526 2 |
| Bile acids synthesis and enterohepatic circulation 0.3731683086620624 0.143139299264551 0.8861801681661052 1.0 1.0 4 P01130 1 |
| Notch signaling pathway 0.300436781975047 0.1412970288870829 0.8876352966728247 1.0 1.0 14 Q96J02,Q92542 2 |
| Glutathione metabolism 0.3513046227664911 0.1369731694825505 0.8910520028456954 1.0 1.0 6 P00390,P48637 2 |
| Photodynamic therapyinduced ap1 survival signaling 0.3428305977082699 0.1348130354908345 0.8927596990988909 1.0 1.0 7 P07900,Q07820,P49327,P04637,P20248,Q16611 6 |
| Erbb signaling pathway 0.2993190996956288 0.1335479027439459 0.8937600826100578 1.0 1.0 17 P31751,P17252,P62993,Q05397,Q13555 5 |
| Base excision repair 0.2940189994430154 0.1252476363557559 0.900327505771497 1.0 1.0 16 Q9NR33 1 |
| Melanoma 0.293547422184878 0.1232067721726789 0.9019433630115694 1.0 1.0 16 P31751,P62993 2 |
| Cardiac hypertrophic response 0.3010643602184664 0.1203190751857296 0.904230394067718 1.0 1.0 13 P31751,P17252,O14920,P50750 4 |
| Cancer immunotherapy by ctla4 blockade 0.5822510822510762 0.1193115598076845 0.9050285255173918 1.0 1.0 2 Q06124 1 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.3525224388734307 0.116761374082672 0.9070491533396978 1.0 1.0 5 O15111,P06753,P18031,P61201 4 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.3427244582043314 0.1149614177731457 0.9084757033866058 1.0 1.0 6 Q7Z434,P19525,O15111,O14920,P42224 5 |
| Dopamine metabolism 0.425157077442191 0.1114532873183931 0.911256906059793 1.0 1.0 3 P17252 1 |
| T cell receptor and costimulatory signaling 0.3397593507879466 0.1076748140357317 0.9142536488241204 1.0 1.0 6 P48729,P17252 2 |
| Physiological and pathological hypertrophy of the heart 0.3377708978328166 0.1028814689381762 0.9180570452925244 1.0 1.0 6 P40763,Q16539,P28482,P61586,P63000 5 |
| Omega3 omega6 fatty acid synthesis 0.3363955041178698 0.0996099278544524 0.9206540117417992 1.0 1.0 6 O15254,Q15067 2 |
| Joubert syndrome 0.2946962213383817 0.0994129371344249 0.9208104113001596 1.0 1.0 18 Q10713,Q13432 2 |
| Type i interferon induction and signaling during sarscov2 infection 0.4160222703371524 0.0991208698430325 0.9210423019469408 1.0 1.0 3 Q7Z434,P42224 2 |
| Gastric cancer network 2 0.2897005114851405 0.0968995059888574 0.922806201126025 1.0 1.0 14 Q14739 1 |
| Estrogen signaling pathway 0.3292040879529217 0.0965635601652688 0.9230729959879208 1.0 1.0 7 P17252,O14920,O15111,Q02750,Q16539,P28482 6 |
| Cellular proteostasis 0.4117788049593325 0.0937388786035588 0.9253165855747538 1.0 1.0 3 P61758 1 |
| Regucalcin in proximal tubule epithelial kidney cells 0.3389043639740107 0.0884668271460794 0.9295056490372132 1.0 1.0 5 P28482,Q8NE86,Q16611,P42345 4 |
| Mirnas involvement in the immune response in sepsis 0.3425123762376232 0.08606424979217 0.9314153426750782 1.0 1.0 4 Q15750,O14920,O15111 3 |
| Hepatitis c and hepatocellular carcinoma 0.2924779227466703 0.0695713139341757 0.9445348697641868 1.0 1.0 12 P31350,P55210 2 |
| Mitochondrial complex i assembly model oxphos system 0.3214474029869262 0.0631510660885046 0.9496462105570068 1.0 1.0 29 Q96CU9,P03886 2 |
| Oxidative damage response 0.3254950495049608 0.0610120452733045 0.9513496161872208 1.0 1.0 4 O95429,Q16611,P12004 3 |
| Microrna network associated with chronic lymphocytic leukemia 0.5142238713667214 0.0582865336956738 0.9535203938330232 1.0 1.0 2 Q07820 1 |
| 15q133 copy number variation syndrome 0.3659140117537938 0.0487734287405955 0.96109985775828 1.0 1.0 3 Q9BXW9,Q16658 2 |
| Folatealcohol and cancer pathway hypotheses 0.4925788497216993 0.0466154054173356 0.9628197536305804 1.0 1.0 2 Q99707 1 |
| Nucleotide excision repair 0.3097732661718758 0.0429079660211996 0.9657748986338774 1.0 1.0 27 Q9NR33,P56282,P41440 3 |
| Dna damage response only atm dependent 0.2935190617154773 0.0428333185817642 0.965834403965974 1.0 1.0 22 P31751,P62993,Q13315,P01130 4 |
| Iron metabolism in placenta 0.4764996907853979 0.0398720824973935 0.9681951083372832 1.0 1.0 2 P21399 1 |
| Cannabinoid receptor signaling 0.3047748040756628 0.0377152307645652 0.9699147322427136 1.0 1.0 7 P10644,Q8NCG7 2 |
| Monoamine transport 0.3424064336529589 0.0340461795250985 0.9728403260919328 1.0 1.0 3 P49815,O15127 2 |
| Cell differentiation expanded index 0.4458874458874375 0.0307490154922224 0.9754697009140528 1.0 1.0 2 P40763 1 |
| Gpr143 in melanocytes and retinal pigment epithelium cells 0.3287967831735282 0.0276415104944564 0.9779480737154038 1.0 1.0 3 P17252,P49407 2 |
| Egfr tyrosine kinase inhibitor resistance 0.2722582414806072 0.0267669443335201 0.9786456183667004 1.0 1.0 17 P08069,P31751,P17252,P62993,P40763 5 |
| Cell cycle 0.3701190240032009 0.0256838076753959 0.979509539200587 1.0 1.0 49 Q13315,Q9UJX6,Q14566,P24941,P20248,P06493,Q9H1A4,Q9Y619,O43913,Q9UJX2,Q99640,Q9UJX4 12 |
| Cytosolic dnasensing pathway 0.2829749726288091 0.0256379548302458 0.9795461124344288 1.0 1.0 11 O14920,P62875,Q86UT6,O15160,Q14258 5 |
| Mammary gland development pathway embryonic development stage 1 of 4 0.3914656771799564 0.0228613761894543 0.9817608496728176 1.0 1.0 2 P23229 1 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.3120940303124085 0.0215731139308653 0.9827884805145036 1.0 1.0 3 P48506,P48637 2 |
| Quercetin and nfkb ap1 induced apoptosis 0.307977736549157 0.0201050164215067 0.9839595984294962 1.0 1.0 2 O14920 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.2924791086351022 0.0166015819533005 0.9867544625166876 1.0 1.0 5 Q07954,P48729,P49841,P35222 4 |
| Hypertrophy model 0.2700278379214402 0.0128603582520133 0.9897392015419864 1.0 1.0 3 P06730,P20248 2 |
| Vitamin dsensitive calcium signaling in depression 0.2923505729327949 0.0127025695534333 0.989865088425095 1.0 1.0 7 P11413,Q8NB78,P00390,P20020,P23634,P48506 6 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.2829720950895737 0.0063313687123911 0.99494833240604 1.0 1.0 5 P55263 1 |
| Rac1pak1p38mmp2 pathway 0.2648166084577305 0.0019132121890471 0.9984734784640944 1.0 1.0 17 O14920,P43246,P62993,P40763,Q05397,P55210 6 |
| Envelope proteins and their potential roles in edmd physiopathology 0.2711841286509399 0.0005008977400847 0.9996003414433576 1.0 1.0 19 P62993,Q14739,P42167,Q8NF91 4 |
|
|
